Published in Rev Med Virol on March 01, 2015
Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia. Viruses (2015) 1.06
Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev (2016) 0.88
Prevalence and Genotype Distribution of HPV Infection in China: Analysis of 51,345 HPV Genotyping Results from China's Largest CAP Certified Laboratory. J Cancer (2016) 0.84
Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients. J Clin Med (2015) 0.83
The critical roles of miR-21 in anti-cancer effects of curcumin. Ann Transl Med (2015) 0.83
Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. Cancer Cell (2016) 0.81
The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses. Sci Rep (2016) 0.81
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites. Cancers (Basel) (2016) 0.79
Control of human papillomavirus gene expression by alternative splicing. Virus Res (2016) 0.78
HPV-p53-miR-34a axis in HPV-associated cancers. Ann Transl Med (2015) 0.78
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis. PLoS Pathog (2016) 0.76
Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue. Virology (2015) 0.76
Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation. Viruses (2017) 0.75
Oncogenic human papillomaviruses. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
HPV disease transmission protection and control. Microb Cell (2016) 0.75
Periodontal pocket as a potential reservoir of high risk human papilloma virus: A pilot study. J Indian Soc Periodontol (2016) 0.75
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatol Ther (Heidelb) (2017) 0.75
MNT and Emerging Concepts of MNT-MYC Antagonism. Genes (Basel) (2017) 0.75
Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis. Oncotarget (2016) 0.75
HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability. J Exp Clin Cancer Res (2016) 0.75
MicroRNAs, signaling pathways and diseases. Ann Transl Med (2015) 0.75
Effects of siRNA-mediated suppression of HPV-11 L1 expression on the proliferation and apoptosis of vaginal epithelial cells. Exp Ther Med (2017) 0.75
A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma. Chin J Cancer (2015) 0.75
Papillomavirus assembly: An overview and perspectives. Virus Res (2016) 0.75
The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog (2017) 0.75
Telomerase Induction in HPV Infection and Oncogenesis. Viruses (2017) 0.75
Analytic and Diagnostic Performances of Human Papillomavirus E6/E7 mRNA Test on up-to 11-Year-Old Liquid-Based Cervical Samples. A Biobank-Based Longitudinal Study. Int J Mol Sci (2017) 0.75
Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection. Viruses (2017) 0.75
Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer. Infect Agent Cancer (2017) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA (2002) 15.59
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol (2009) 4.51
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis (2010) 4.42
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol (2008) 4.17
Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) (2006) 3.74
Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (1996) 3.61
Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol (1995) 3.57
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell (2000) 3.44
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer (2012) 3.35
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Maturation of papillomavirus capsids. J Virol (2005) 3.18
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol (1991) 3.10
Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A (1995) 2.79
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol (2000) 2.55
The biology and life-cycle of human papillomaviruses. Vaccine (2012) 2.53
Subunit interactions in bovine papillomavirus. Proc Natl Acad Sci U S A (2010) 2.51
Papillomaviruses infect cells via a clathrin-dependent pathway. Virology (2003) 2.47
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J (1999) 2.44
Guidelines for the management of cutaneous warts. Br J Dermatol (2001) 2.42
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck (2012) 2.40
Immune responses to human papillomavirus. Vaccine (2006) 2.37
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol (2008) 2.37
The human papillomavirus E7 oncoprotein. Virology (2008) 2.32
Atomic model of the papillomavirus capsid. EMBO J (2002) 2.27
Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol (1992) 2.24
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23
The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res (2002) 2.16
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell (2005) 2.13
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (2001) 2.12
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol (1998) 2.12
Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis (2010) 2.10
Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature (1991) 2.09
Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A (1996) 2.06
The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol (1993) 2.04
Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol (2000) 2.03
Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol (2003) 2.02
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene (2003) 2.00
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97
Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96
Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog (2009) 1.94
Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol (2007) 1.93
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res (2004) 1.90
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A (2009) 1.90
Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer (2004) 1.90
Cross-roads in the classification of papillomaviruses. Virology (2013) 1.87
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res (2008) 1.83
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82
Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol (2003) 1.82
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol (2003) 1.79
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol (2003) 1.79
Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene (1992) 1.76
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog (2012) 1.76
Current understanding of the mechanism of HPV infection. Gynecol Oncol (2010) 1.74
Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene (2006) 1.71
One virus, one lesion--individual components of CIN lesions contain a specific HPV type. J Pathol (2012) 1.67
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell (2006) 1.67
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology (1997) 1.66
A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A (2012) 1.64
Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62
Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene (2003) 1.59
Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol (2012) 1.58
E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J Virol (2001) 1.58
Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology (1997) 1.56
Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res (2004) 1.56
Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis (2007) 1.54
Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A (2011) 1.53
The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol (2005) 1.53
Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA. Int J Cancer (1988) 1.53
Regulation of epidermal differentiation by a Distal-less homeodomain gene. J Cell Biol (1996) 1.49
Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J Virol (2003) 1.49
Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology (1989) 1.46
Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J Mol Biol (2001) 1.46
The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene (1999) 1.44
Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet (2003) 1.42
The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells. J Cell Sci (2006) 1.42
Interactions between papillomavirus L1 and L2 capsid proteins. J Virol (2003) 1.41
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer (2011) 1.41
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter. Cancer Res (2003) 1.40
Verrucous cyst. Arch Dermatol (1991) 1.40
Human papillomavirus vaccines--immune responses. Vaccine (2012) 1.40
ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol Cell (2006) 1.39
Epidermoid cyst of the scalp containing human papillomavirus. J Cutan Pathol (1993) 1.39
Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res (2008) 1.38
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases. J Am Acad Dermatol (2003) 1.36
Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer. Clin Cancer Res (2010) 2.05
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol (2003) 1.79
DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells. Cancer Res (2010) 1.14
Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol (2004) 1.10
An in vitro multistep carcinogenesis model for human cervical cancer. Cancer Res (2008) 1.05
PDZ domains: the building blocks regulating tumorigenesis. Biochem J (2011) 1.04
Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J (2012) 1.04
Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance. Virology (2011) 1.02
Reconstruction of human papillomavirus type 16-mediated early-stage neoplasia implicates E6/E7 deregulation and the loss of contact inhibition in neoplastic progression. J Virol (2012) 0.95
Carcinogenic human papillomavirus infection. Nat Rev Dis Prim (2016) 0.95
Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides. J Mol Biol (2004) 0.93
Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J (2011) 0.91
High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells. Cancer Sci (2009) 0.88
Synthetic emmprin peptides inhibit tumor cell-fibroblast interaction-stimulated upregulation of MMP-2 and tumor cell invasion. Int J Oncol (2011) 0.87
A pilot study of the multiherb Kampo medicine bakumondoto for cough in patients with chronic obstructive pulmonary disease. Phytomedicine (2010) 0.86
Intrabody strategies for the treatment of human papillomavirus-associated disease. Expert Opin Biol Ther (2007) 0.85
A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.81
A novel interaction between hScrib and PP1γ downregulates ERK signaling and suppresses oncogene-induced cell transformation. PLoS One (2013) 0.81
The mechanism and implications of hScrib regulation of ERK. Small GTPases (2010) 0.79
Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lung. Anticancer Res (2012) 0.79
Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator. J Gene Med (2009) 0.78
A heavily pretreated patient with recurrent clear cell adenocarcinoma of the ovary in whom carcinomatous peritonitis was controlled successfully by salvage therapy with gemcitabine. Arch Gynecol Obstet (2007) 0.77
Epidermodysplasia-verruciformis-like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia. Dermatology (2009) 0.77
Association of EPAS1 gene rs4953354 polymorphism with susceptibility to lung adenocarcinoma in female Japanese non-smokers. J Thorac Oncol (2014) 0.76
Molecular cloning and characterisation of a novel type of human papillomavirus 160 isolated from a flat wart of an immunocompetent patient. PLoS One (2013) 0.76
Detection of Papillomavirus Gene Expression Patterns in Tissue Sections. Curr Protoc Microbiol (2016) 0.76
An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas. Am J Cancer Res (2011) 0.76
[Repeated tuberculin skin tests in nurse students--observation for 3 years]. Kekkaku (2002) 0.75
A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS. Carcinogenesis (2012) 0.75
Endobronchial ultrasonography with a guide-sheath and virtual bronchoscopy navigation aids management of peripheral pulmonary nodules. Hiroshima J Med Sci (2007) 0.75
[Case of pulmonary pseudallescheriasis responding successfully to treatment with voriconazole]. Nihon Kokyuki Gakkai Zasshi (2007) 0.75
In-vitro and clinical evaluation of an oral mucosal adhesive film containing indomethacin. Yakugaku Zasshi (2008) 0.75
Virtual bronchoscopy aids management of lung cancer. Respirology (2007) 0.75
Identification of proteins that associate with integrin α2 by proteomic analysis in human fibrosarcoma HT-1080 cells. J Cell Physiol (2012) 0.75